Putting the Pieces in Place to Support IND Submissions — and an IPO
Drug discovery, development, and commercialization is like a puzzle. The end may be easy to visualize, but there are many pieces that need to be…
Abstract: Meeting compliance issues is like preparing for a hurricane: both situations require making sure that everything is nailed down well before the storm hits. IPM’s Greg Kain shares the six rules for pharmaceutical companies facing regulatory compliance issues, and how a process-driven approach can help minimize the pain.
Service: Regulatory & Quality
Industry: Life Sciences
— Published December 5, 2013